• article not found
  • Filters close
    23-Nov-2024 6:20 AM EST
    Common Diabetes Drug Shows Promise for Reducing Harmful Alcohol Use
    Research Society on Alcoholism

    An early-stage study has found that a drug commonly prescribed for diabetes may prove to help treat people with alcohol use disorder. The study, published in Alcohol: Clinical and Experimental Research, found that the diabetes drug metformin reduced alcohol intake in mice.

         
    Released: 26-Nov-2024 9:50 AM EST
    Using Antibiotics Alone to Treat Children with Appendicitis Is a Cost-Effective and Safe Alternative to Surgery, Study Shows
    American College of Surgeons (ACS)

    Using antibiotics alone to treat children with uncomplicated appendicitis is a cost-saving alternative to surgery.

    Newswise: Squishy Microgels in Granular Biomaterials Confine and Direct Cell Behavior
    Released: 26-Nov-2024 9:45 AM EST
    Squishy Microgels in Granular Biomaterials Confine and Direct Cell Behavior
    Penn State Materials Research Institute

    A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical treatments such as wound healing, cancer therapy and even organ regeneration, according to a research team at Penn State.

    Released: 26-Nov-2024 9:35 AM EST
    Moffitt Study Shows How Cancer Cell Death May Harm the Immune System and Promote Tumor Growth
    Moffitt Cancer Center

    A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell death can actually make tumors grow faster by turning off the immune system’s ability to fight the cancer.

    Newswise: Breakthroughs in Thermal Photonics Enable Efficient Subambient Daytime Radiative Cooling for Vertical Surfaces
    Released: 26-Nov-2024 9:25 AM EST
    Breakthroughs in Thermal Photonics Enable Efficient Subambient Daytime Radiative Cooling for Vertical Surfaces
    Chinese Academy of Sciences

    A groundbreaking study published in Science has achieved a significant advancement in thermal photonics, enabling efficient subambient daytime radiative cooling for vertical surfaces.

    Released: 26-Nov-2024 9:15 AM EST
    Advancing Breast Cancer Research: Yale Cancer Center to Share Insights at International Conference
    Yale Cancer Center/Smilow Cancer Hospital

    Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 47th annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center from December 10 to 13.

    Newswise: Supercharging Hydrogen Production: NiPS3's Vacancy Trick
    Released: 26-Nov-2024 9:10 AM EST
    Supercharging Hydrogen Production: NiPS3's Vacancy Trick
    Chinese Academy of Sciences

    Scientists have unveiled a strategy to amplify the catalytic power of two-dimensional NiPS3 monolayers for hydrogen evolution reactions (HER). By introducing and strategically manipulating atomic vacancies, this innovative approach enhances the material’s ability to split water molecules and absorb protons.

    Released: 26-Nov-2024 8:30 AM EST
    Digital Science Teams Up with Huron to Strengthen Research Security and Compliance for Education and Research Clients
    Digital Science and Research Solutions Ltd

    Digital Science is pleased to announce that global professional services firm Huron will integrate Dimensions Research Security into its suite of services to support clients in the research and higher education sectors.

           
    Released: 26-Nov-2024 8:00 AM EST
    American Thyroid Association® Announces 2024-2025 Officers and Board of Directors
    American Thyroid Association

    American Thyroid Association® announces Jacqueline Jonklaas, MD, PhD, as 2024-2025 President and five new officers and members of the Board of Directors.

    Newswise: Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients
    Released: 26-Nov-2024 8:00 AM EST
    Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients
    Roswell Park Comprehensive Cancer Center

    A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.

    Newswise: Virtual Replicas for Real-World Solutions: Digital Twins in Action
    Released: 26-Nov-2024 7:50 AM EST
    Virtual Replicas for Real-World Solutions: Digital Twins in Action
    Chinese Academy of Sciences

    In a significant advancement for industrial technology, scientists have introduced a revolutionary digital twin (DT) platform designed to transform the process industry. This cutting-edge platform creates a highly accurate virtual replica of physical systems, allowing companies to optimize operations, enhance productivity, and fuel innovation like never before.

    Newswise: Beyond Lithium: The Rise of Sustainable Battery Alternatives
    Released: 26-Nov-2024 7:35 AM EST
    Beyond Lithium: The Rise of Sustainable Battery Alternatives
    Chinese Academy of Sciences

    Scientists are exploring non-lithium-ion batteries as a sustainable alternative to traditional lithium-ion batteries, focusing on sodium, potassium, magnesium, and calcium-ion technologies. This research is crucial for developing clean energy systems that are both environmentally friendly and rely on abundantly available elements, ensuring a more secure and eco-friendly future for energy storage.

    Newswise: Novel Gene Therapy Trial for Sickle Cell Disease Launches
    Released: 26-Nov-2024 7:30 AM EST
    Novel Gene Therapy Trial for Sickle Cell Disease Launches
    University of California, San Francisco (UCSF)

    UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.

    Newswise: Behind the Model: Science Inspired by Legos
    Released: 26-Nov-2024 7:00 AM EST
    Behind the Model: Science Inspired by Legos
    Thomas Jefferson National Accelerator Facility

    Walt Akers, Jefferson Lab’s chief systems engineer for experimental nuclear physics, created a 3D-printed model of a section of the Electron-Ion Collider (EIC) on a short timeline ahead of the lab’s 2024 Open House. He calls it the “Lego model.”

    23-Nov-2024 11:45 PM EST
    Quantifying Disease Impact and Overcoming Practical Treatment Barriers for Primary Progressive Aphasia
    University of Chicago Medical Center

    Two new papers show progress in researchers' work to illuminate the struggles of those living with PPA and pioneer accessible treatment models.



    close
    0.13821